Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder

摘要

Use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, or its hydrates, crystalline forms and addition salts with a pharmaceutically acceptable acid or base, in obtaining a medicament intended for the treatment of Generalized Anxiety Disorder is disclosed. The crystalline II form of agomelatine is particularly suitable for the treatment of Generalized Anxiety Disorder.